Low Dose Aspirin Inhibition of COX-2 Derived PGE2 in Male Smokers
Clinical trial NCT01796951 · COMPLETED
Trial details
- NCT number
- NCT01796951
- Sponsor
- Vanderbilt University
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-01
- Primary completion
- 2016-02-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.